Patents by Inventor Zitao ZENG

Zitao ZENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230334292
    Abstract: Embodiments of this application disclose a node fusion method for a computational graph and a device. The method includes: converting a neural network into a computational graph; extracting one or more parallelizable branch groups from the computational graph based on a dependency relationship between nodes in the computational graph, where the dependency relationship indicates at least one of the following relationships: the parallelizable branch group has a common parent node, the parallelizable branch group has a common child node, the parallelizable branch group has no parent node, and the parallelizable branch group has no child node; and finally, fusing a plurality of nodes in any parallelizable branch group that respectively belong to different sub-branches to obtain a new computational graph.
    Type: Application
    Filed: June 26, 2023
    Publication date: October 19, 2023
    Inventors: Zhaochuang ZHANG, Xiong GAO, Zitao ZENG
  • Publication number: 20220317121
    Abstract: A method can be used for detecting, in a sample, an autoantibody binding to a polypeptide having the sequence SEQ ID NO: 1, SEQ ID NO: 11 or SEQ ID NO: 24. A carrier containing said polypeptide and an autoantibody binding to said polypeptide are useful. The autoantibody may be used for the diagnosis of a disease, and a method can be used for isolating an autoantibody binding to said polypeptide. The polypeptide and a kit containing said polypeptide are useful, and can be used for the manufacture of a kit or medical device. A method involves contacting a medical or diagnostic device containing said polypeptide with a buffered solution containing an antibody binding specifically to said polypeptide. A sample containing said autoantibody as a positive control and a diluted sample containing said autoantibody are useful.
    Type: Application
    Filed: March 23, 2022
    Publication date: October 6, 2022
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Zitao ZENG, Lars Komorowski, Ramona Miske, Madeleine Scharf, Yvonne Denno, Christiane Radzimski, Nadine Rochow, Stefanie Brakopp